Showing 1 to 15 of 68 entries
BUY
Allan Tong’s Discover Picks Among the caveats here is that HHL doesn't offer much growth. HHL is currently trading 30 cents above its 2022 low of $7.55, but its high is only $9.05. If you buy at current levels, add the dividend and subtract the MER, you're collecting a 13.5% return over a year. Not bad in these volatile times. Read 3 Best U.S. Healthcare ETFs for our full analysis.
E.T.F.'s
Unspecified
It is a very large cap fund. Does some covered writing which gives away some upside. Whether you buy or not depends on your view of the health care space. It is 40% pharmaceuticals, 19% health care supplies, 15% health care services.
E.T.F.'s
BUY
Believes healthcare sector is good for investors looking for yield (demand not going away). Not a growth story, but will provide stability.
E.T.F.'s
BUY
Interesting company due to strong yield. Main issue is not as strong of growth as other stocks. Return has been strong regardless. Good for investors looking for income, but not growth.
E.T.F.'s
BUY

Invests in healthcare issuers, a space he likes. Healthcare offers growth and defence and does well in late cycles and recessions. Pays enhanced dividends, too, with options totalling 8.7% dividends. The MER is around 1%, which is a little high. Covered calls do well in flat or down markets. Covered calls are also very tax efficient.

E.T.F.'s
BUY on WEAKNESS

HHL-T vs ZEB-T Canadian banks good long-term investment. European banks good as well. Canada doesn't have much exposure to healthcare stocks but they're going to be part of the future. HHL could be a way to play that. Have to think diversified. Good to make room for both of them in your portfolio.

E.T.F.'s
TOP PICK
Likes the US healthcare industry, as all the aging baby boomers are entering high medical cost years. Covid delayed a lot of elective surgeries, creating a backlog. The yield on this ETF is extraordinary. He's trying this for his yield-oriented investors to make up for abysmal fixed income returns.
E.T.F.'s
COMMENT
Hedged, unhedged, and USD versions. 20 large-cap US healthcare stocks, with a covered call strategy. Dividend comes from underlying securities plus covered calls. Because volatility is up so much, he's writing fewer calls to generate the same cashflow. He doesn't expect any changes to the distribution.
E.T.F.'s
BUY
Would go for the defensive nature and dividend slant of the Harvest fund. It makes sense to be defensive. MER is a little higher but worth it for the active management. It has a longer term growth aspect to it as well.
E.T.F.'s
BUY
His firm manages this. Contains 20 large cap healthcare companies, with a covered call strategy. Good for monthly cashflow. If you want more beta, there are other alternatives. Over the last year, large cap has absolutely dominated small caps, and he doesn't see this abating this year. Yield north of 8%.
E.T.F.'s
BUY on WEAKNESS
Late in the cycle, healthcare tends to outperform and is less sensitive to volatility. If the broad markets pull back, he would wait for the uncertainty to be priced in more.
E.T.F.'s
BUY
Harvest has many covered call ETFs, using 25-30% of the stocks within an ETF that is a covered call. If you want yield, these look attractive, all the Harvest ETFs. But he's not 100% certain how they work, but has never heard of any problems. Generally, this is good.
E.T.F.'s
BUY
Healthcare is a great area that is robust to growth shocks. The yield is also enhanced by the covered call writing. A good compliment for Canadians to diversify. Has a place in a portfolio.
E.T.F.'s
BUY

For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.

E.T.F.'s
BUY

For income in retirement account. Would prefer ZWU to HHL. If markets correct over the next few quarters, there will be more correction in HHL. Likes both and are both buys in pull backs.

E.T.F.'s
Showing 1 to 15 of 68 entries

Healthcare Leaders Income Fund(HHL-T) Rating

Ranking : 5 out of 5

Bullish - Buy Signals / Votes : 9

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 9

Stockchase rating for Healthcare Leaders Income Fund is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Healthcare Leaders Income Fund(HHL-T) Frequently Asked Questions

What is Healthcare Leaders Income Fund stock symbol?

Healthcare Leaders Income Fund is a Canadian stock, trading under the symbol HHL-T on the Toronto Stock Exchange (HHL-CT). It is usually referred to as TSX:HHL or HHL-T

Is Healthcare Leaders Income Fund a buy or a sell?

In the last year, 9 stock analysts published opinions about HHL-T. 9 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Healthcare Leaders Income Fund.

Is Healthcare Leaders Income Fund a good investment or a top pick?

Healthcare Leaders Income Fund was recommended as a Top Pick by on . Read the latest stock experts ratings for Healthcare Leaders Income Fund.

Why is Healthcare Leaders Income Fund stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Healthcare Leaders Income Fund worth watching?

9 stock analysts on Stockchase covered Healthcare Leaders Income Fund In the last year. It is a trending stock that is worth watching.

What is Healthcare Leaders Income Fund stock price?

On 2022-09-28, Healthcare Leaders Income Fund (HHL-T) stock closed at a price of $7.59.